RubenfeldGD, CaldwellE, PeabodyE, WeaverJ, MartinDP, NeffM, et al. Incidence and outcomes of acute lung injury. N Engl J Med, 2005; 353(16):1685-1693.
2.
The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med, 2000; 342(18):1301-1308.
3.
VarpulaT, ValtaP, NiemiR, TakkunenO, HynynenM, PettiläVV. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand, 2004; 48(6):722-731.
4.
FergusonND, CookDJ, GuyattGH, MehtaS, HandL, AustinP, et al. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med, 2013; 368(9):795-805.
5.
GattinoniL, CaironiP, CressoniM, ChiumelloD, RanieriVM, QuintelM, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med, 2006; 354(17):1775-1786.
6.
MercatA, RichardJC, VielleB, JaberS, OsmanD, DiehlJL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA, 2008; 299(6):646-655.
7.
GuérinC, ReignierJ, RichardJC. Prone positioning in the acute respiratory distress syndrome. N Engl J Med, 2013; 369(10):980-981.
8.
PeekGJ, MugfordM, TiruvoipatiR, WilsonA, AllenE, ThalananyMM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet, 2009; 374(9698):1351-1363.
9.
PapazianL, ForelJM, GacouinA, Penot-RagonC, PerrinG, LoundouA, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med, 2010; 363(12):1107-1116.
10.
MeduriGU, HeadleyAS, GoldenE, CarsonSJ, UmbergerRA, KelsoT, TolleyEA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA, 1998; 280(2):159-165.
11.
SteinbergKP, HudsonLD, GoodmanRB, HoughCL, LankenPN, HyzyR, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med, 2006; 354(16):1671-1684.
12.
TaylorRW, ZimmermanJL, DellingerRP, StraubeRC, CrinerGJ, DavisKJr., et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA, 2004; 291(13):1603-1609.
13.
TorbicH, SzumitaPM, AngerKE, NuccioP, LaGambinaS, WeinhouseG. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care, 2013; 28(5):844-848.
DahlemP, van AalderenWM, de NeefM, DijkgraafMG, BosAP. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury. Crit Care Med, 2004; 32(4):1055-1060.
16.
DunkleyKA, LouzonPR, LeeJ, VuS. Efficacy, safety, and medication errors associated with the use of inhaled epoprostenol for adults with acute respiratory distress syndrome: a pilot study. Ann Pharmacother, 2013; 47(6):790-796.
17.
PacheoJ, ArnoldH, SkrupkyL, WattsP, MicekST, KollefMH. Predictors of outcome in 216 subjects with ARDS treated with inhaled epoprostenol. Respir Care, 2014; 59(8):1178-1185.
18.
McClintockD, ZhuoH, WickershamN, MatthayMA, WareLB. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care, 2008; 12(2):R41.
19.
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, WiedemannHP, WheelerAP, BernardGR, ThompsonBT, HaydenD, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med, 2006; 354(24):2564-2575.
20.
ARDS Definition Task Force, RanieriVM, RubenfeldGD, ThompsonBT, FergusonND, CaldwellE, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA, 2012; 307(23):2526-2533.
